A5 is a global nonprofit organization dedicated to advancing adrenal research through international collaboration and innovation.
A5 is a growing international network of more than 50 leading academic and medical institutions, united by a shared mission to drive progress in adrenal disorders research. Our members span continents — from the Americas to Asia and Australia — bringing together diverse perspectives, expertise, and innovative ideas to tackle the complexities of adrenal cancer. The community also actively collaborates with the European Network for the study of Adrenal Tumors (ENSAT) which led to the launching of important studies and clinical trials.
A5 partners with several key research networks and working groups across the globe. These sister organizations are pivotal in advancing adrenal disorders research through collaborative studies, data sharing, and groundbreaking innovations. These working groups contribute to large-scale research projects and clinical trials, making significant strides in understanding and treating adrenal cancers.
Our leadership team consists of distinguished researchers and clinicians who guide A5’s strategy, governance, and initiatives. Together, they shape the organization’s mission, ensuring A5 remains at the forefront of adrenal tumor research.
A5 is a growing organization made up of clinicians, researchers, trainees, students, and advocates from more than 50 major academic and research centers in the three continents. Support adrenal research and become part of a growing global network!
